357 related articles for article (PubMed ID: 31285612)
21. Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer.
Vidula N; Yau C; Rugo HS
Breast Cancer Res Treat; 2021 Jun; 187(2):387-395. PubMed ID: 33913053
[TBL] [Abstract][Full Text] [Related]
22. Effects of heterologous cross-suture between the postganglionic sympathetic and the preganglionic parasympathetic nerve trunks of submandibular glands in cats.
Kemplay SK; Garrett JR
Cell Tissue Res; 1976 Mar; 167(2):197-210. PubMed ID: 1260843
[TBL] [Abstract][Full Text] [Related]
23. Defective pulmonary innervation and autonomic imbalance in congenital diaphragmatic hernia.
Lath NR; Galambos C; Rocha AB; Malek M; Gittes GK; Potoka DA
Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L390-8. PubMed ID: 22114150
[TBL] [Abstract][Full Text] [Related]
24. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases.
Manson QF; Schrijver WAME; Ter Hoeve ND; Moelans CB; van Diest PJ
Clin Exp Metastasis; 2019 Feb; 36(1):29-37. PubMed ID: 30547271
[TBL] [Abstract][Full Text] [Related]
25. Developmental regulation of parasympathetic nerve density by sympathetic innervation in the tarsal smooth muscle of the rat.
Sharp CE; Smith PG
Neuroscience; 1992 Jul; 49(1):229-36. PubMed ID: 1407549
[TBL] [Abstract][Full Text] [Related]
26. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer.
Szpunar MJ; Belcher EK; Dawes RP; Madden KS
Brain Behav Immun; 2016 Mar; 53():223-233. PubMed ID: 26718447
[TBL] [Abstract][Full Text] [Related]
27. Differences in autonomic innervation to the vertebrobasilar arteries in spontaneously hypertensive and Wistar rats.
Roloff EVL; Walas D; Moraes DJA; Kasparov S; Paton JFR
J Physiol; 2018 Aug; 596(16):3505-3529. PubMed ID: 29797726
[TBL] [Abstract][Full Text] [Related]
28. Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants.
Saleh R; Toor SM; Al-Ali D; Sasidharan Nair V; Elkord E
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32616706
[TBL] [Abstract][Full Text] [Related]
29. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
[TBL] [Abstract][Full Text] [Related]
30. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
Kassardjian A; Shintaku PI; Moatamed NA
PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
[TBL] [Abstract][Full Text] [Related]
31. Autonomic nerve development contributes to prostate cancer progression.
Magnon C; Hall SJ; Lin J; Xue X; Gerber L; Freedland SJ; Frenette PS
Science; 2013 Jul; 341(6142):1236361. PubMed ID: 23846904
[TBL] [Abstract][Full Text] [Related]
32. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
33. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression.
Jiao S; Xia W; Yamaguchi H; Wei Y; Chen MK; Hsu JM; Hsu JL; Yu WH; Du Y; Lee HH; Li CW; Chou CK; Lim SO; Chang SS; Litton J; Arun B; Hortobagyi GN; Hung MC
Clin Cancer Res; 2017 Jul; 23(14):3711-3720. PubMed ID: 28167507
[No Abstract] [Full Text] [Related]
34. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X; Li X; Wei X; Jiang H; Lan C; Yang S; Wang H; Yang Y; Tian C; Xu Z; Zhang J; Hao J; Ren H
Signal Transduct Target Ther; 2020 Apr; 5(1):38. PubMed ID: 32300119
[TBL] [Abstract][Full Text] [Related]
35. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine.
Hassannia H; Ghasemi Chaleshtari M; Atyabi F; Nosouhian M; Masjedi A; Hojjat-Farsangi M; Namdar A; Azizi G; Mohammadi H; Ghalamfarsa G; Sabz G; Hasanzadeh S; Yousefi M; Jadidi-Niaragh F
Immunology; 2020 Jan; 159(1):75-87. PubMed ID: 31587253
[TBL] [Abstract][Full Text] [Related]
36. Parasympathetic, sympathetic, and sensory interactions in the iris: nerve growth factor regulates cholinergic ciliary ganglion innervation in vivo.
Kessler JA
J Neurosci; 1985 Oct; 5(10):2719-25. PubMed ID: 2413184
[TBL] [Abstract][Full Text] [Related]
37. Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD?
Orimo S; Ghebremedhin E; Gelpi E
Cell Tissue Res; 2018 Jul; 373(1):267-286. PubMed ID: 29869180
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors.
Goodman AM; Piccioni D; Kato S; Boichard A; Wang HY; Frampton G; Lippman SM; Connelly C; Fabrizio D; Miller V; Sicklick JK; Kurzrock R
JAMA Oncol; 2018 Sep; 4(9):1237-1244. PubMed ID: 29902298
[TBL] [Abstract][Full Text] [Related]
39. Interaction between cerebrovascular sympathetic, parasympathetic and sensory nerves in blood flow regulation.
Morita-Tsuzuki Y; Hardebo JE; Bouskela E
J Vasc Res; 1993; 30(5):263-71. PubMed ID: 8399987
[TBL] [Abstract][Full Text] [Related]
40. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
